Clover Health Investments (CLOV) Amortization - Deferred Charges (2020 - 2022)

Clover Health Investments (CLOV) has 3 years of Amortization - Deferred Charges data on file, last reported at $3000.0 in Q4 2022.

• For the quarter ending Q4 2022, Amortization - Deferred Charges fell 66.67% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2023 stood at $3000.0 (down 90.0% YoY), and the FY2022 full-year result was $30000.0, down 99.78% from the prior year.
• Amortization - Deferred Charges for Q4 2022 stood at $3000.0, down from $9000.0 in the prior quarter.
• Across five years, Amortization - Deferred Charges topped out at $13.7 million in Q1 2021 and bottomed at $3000.0 in Q4 2022.
• The 3-year median for Amortization - Deferred Charges is $22000.0 (2021), against an average of $2.7 million.
• The widest annual swing landed in 2021, when Amortization - Deferred Charges plunged 99.85%; it then plunged 30.77% in 2022.
• A 3-year view of Amortization - Deferred Charges shows it stood at $6.2 million in 2020, then slumped by 99.85% to $9000.0 in 2021, then sank by 66.67% to $3000.0 in 2022.
• The last three Amortization - Deferred Charges figures came in at $3000.0 (Q4 2022), $9000.0 (Q3 2022), and $18000.0 (Q2 2022), per Business Quant data.

Peer Comparison